Trial · NCT05223361
Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery
NCT05223361, Phase 3, Completed, Rajaie Cardiovascular Medical and Research Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery. Trials, record NCT05223361. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05223361
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery
- NCT number
- NCT05223361
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 120 participants, actual
- Lead sponsor
- Rajaie Cardiovascular Medical and Research Center
- Conditions
- Heart Valve Diseases
- Interventions
- Six percent hydroxy ethyl starch 130/0.4, Ringer lactate
- First posted
- 2022-02-03
- Last updated
- 2022-02-03
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of participants required blood transfusion | Up to discharge, an average of 8 days | The volume of blood transfusion after heart valve surgery |
| Secondary | Number of participants died in hospital | Up to discharge, an average of 8 days | Any cause of death after heart valve surgery |
| Secondary | Duration of ventilation time | During ICU admission, an average of 2 days | The duration ventilation time after heart valve surgery |
| Secondary | ICU length of stay | During ICU admission, an average of 2 days | The length of stay in intensive care unit |
| Secondary | Hospital length of stay | During hospital admission, an average of 8 days | The length of stay in hospital after heart valve surgery |
| Secondary | Number of participants required chest tube drainage | During hospital admission, an average of 8 days | The amount of drainage from chest tube after heart valve surgery |
| Secondary | Number of participants required re-operation for bleeding | During hospital admission, an average of 8 days | Re-operation due to excessive bleeding after heart valve surgery |
| Secondary | Number of participants died in one month | One month after surgery | Any cause of death within one month after heart valve surgery |
| Secondary | Changes in hemoglobin concentration | Up to 48 hours after heart valve surgery | Changes in hemoglobin after heart valve surgery |
| Secondary | Changes in hematocrit concentration | Up to 48 hours after heart valve surgery | Changes in hematocrit after heart valve surgery |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 38105566 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05223361
GET https://conductscience.org/api/trials/v1/NCT05223361/registered